Inhibikase Therapeutics, Inc.
← Back to IKT Overview

Inhibikase Therapeutics, Inc. (IKT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.47

Financial Fundamentals

IKTQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-03-31-106.07
2017-12-31573.36
2018-03-31-154.37
2018-12-31-20.07
2019-03-31-11.69
2019-06-30-8.63
2019-09-30-16.69
2019-12-31-46.41
2020-03-31-37.13
2020-06-30-47.90
2020-09-30-30.31
2020-12-31-11.90
2021-03-31-5.74
2021-06-30-3.26
2021-09-30-2.66
2021-12-31-1.84
2022-03-31-2.02
2022-06-30-1.01
2022-09-30-1.28
2022-12-31-0.74
2023-03-31-1.01
2023-06-30-0.81
2023-09-30-0.40
2023-12-31-0.47
2024-03-31-0.74
2024-06-30-0.47
2024-09-30-0.50
2024-12-31-4.78
2025-03-31-3.65
2025-06-30-4.43
2025-09-30-3.12
2025-12-31-3.94
2026-03-31-2.47

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.